Rosuvastatin 20 Mg Oral Tablet

DRUG4 trials

Conditions

Coronary Artery Disease ProgressionCoronary Artery Disease Risk Factors MultipleDiabetes MellitusHydroxymethylglutaryl-CoA Reductase InhibitorsNonalcoholic SteatohepatitisPeripheral Nerve DiseasePremature AtherosclerosisPrevention & Control

Phase 2

Neuroprotection of Memantine and Rosuvastatin

Not yet recruitingNCT07504198

Tanta UniversityPeripheral Nerve Disease

Start: 2026-03-01End: 2027-05-01Target: 46Updated: 2026-03-31

Phase 3

Comparative Clinical Study to Evaluate the Efficacy and Safety of Rosuvastatin Vs CoQ10 on Nonalcoholic Steatohepatitis

NCT05731596

Tanta UniversityNonalcoholic Steatohepatitis

Start: 2023-06-30End: 2024-04-30Target: 46Updated: 2023-05-16

PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis

Not yet recruitingNCT07232069

Duke UniversityCoronary Artery Disease Progression, Coronary Artery Disease Risk Factors Multiple, Premature Atherosclerosis +1

Start: 2026-07-01End: 2031-07-01Target: 1500Updated: 2026-02-27

Unknown Phase

Statins in Patients With Type 2 Diabetes Mellitus and Previous History of Acute Coronary Syndrome

CompletedNCT05306990

Helwan UniversityDiabetes Mellitus, Hydroxymethylglutaryl-CoA Reductase Inhibitors

Start: 2017-04-20End: 2021-01-31Updated: 2022-04-01

Related Papers

Efficacy and Safety of Atorvastatin 40 mg versus Rosuvastatin 20 mg in Patients with Type 2 Diabetes Mellitus and Previous Acute Coronary Syndrome: A Randomized Clinical Trial